1. Home
  2. PRTH vs DNA Comparison

PRTH vs DNA Comparison

Compare PRTH & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$6.20

Market Cap

485.9M

Sector

Technology

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.79

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
DNA
Founded
2005
2008
Country
United States
United States
Employees
1200
485
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.9M
455.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRTH
DNA
Price
$6.20
$7.79
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$8.33
$8.50
AVG Volume (30 Days)
202.9K
1.2M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.76
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$10.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.44
$5.37
52 Week High
$8.89
$17.58

Technical Indicators

Market Signals
Indicator
PRTH
DNA
Relative Strength Index (RSI) 57.61 43.08
Support Level $5.33 $7.59
Resistance Level $6.75 $9.58
Average True Range (ATR) 0.28 0.76
MACD -0.03 -0.14
Stochastic Oscillator 49.52 5.86

Price Performance

Historical Comparison
PRTH
DNA

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: